deoxypyridinoline has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaba, M; Ishimura, E; Maeno, Y; Nishizawa, Y; Okuno, S; Ueda, M; Yamakawa, T | 1 |
| Imanishi, Y; Inaba, M; Ishimura, E; Kim, M; Kumeda, Y; Kurioka, Y; Maekawa, K; Morii, H; Nagasue, K; Nishizawa, Y; Ohta, T; Okuno, S; Otoshi, T | 1 |
1 trial(s) available for deoxypyridinoline and Diabetic Nephropathies
| Article | Year |
|---|---|
Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Male; Osteocalcin; Parathyroid Hormone; Renal Dialysis | 2001 |
1 other study(ies) available for deoxypyridinoline and Diabetic Nephropathies
| Article | Year |
|---|---|
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Topics: Absorptiometry, Photon; Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcium; Collagen; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptide Fragments; Procollagen; Renal Dialysis; Retrospective Studies | 2005 |